An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV ...

A leading cause of birth defects is a virus that many expectant parents have never heard about. That may change soon thanks to the advocacy of parents whose children suffered birth defects due to the ...

New York is now screening all newborns for congenital Cytomegalovirus to improve access to early treatments for the viral infection that can cause hearing and vision loss, seizures and intellectual ...

Cytomegalovirus or CMV, is a member of the herpes virus family. Coming into contact with the CMV virus is a common occurrence and is typically harmless to the general population. A CMV infection ...

That led to CMV as a suspect, Hackam says. An estimated 40% to 80% of people worldwide are chronically infected with cytomegalovirus, a virus in the herpes family that doesn't usually cause symptoms ...

Lily Belle never got to grow up, be a sister or experience the world, writes Arissa Viering. But with the right awareness and medical research, we might have been able to save her life. iStock ...

Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of passing the virus to newborns. But top-line data the company released ...

Researchers have uncovered a compelling potential link between a chronic gut infection caused by a common virus and the ...

Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.

A new mRNA vaccine in phase 3 clinical trials is better at triggering the immune system to fight cytomegalovirus infection.